HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
BBS12
Bardet-Biedl syndrome 12
Chromosome 4 Β· 4q27
NCBI Gene: 166379Ensembl: ENSG00000181004.10HGNC: HGNC:26648UniProt: Q6ZW61
21PubMed Papers
21Diseases
0Drugs
183Pathogenic Variants
RESEARCH IMPACT
Variant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
chaperone-mediated protein complex assemblyprotein bindingnegative regulation of fat cell differentiationphotoreceptor cell maintenanceBardet-Biedl syndrome 12Bardet-Biedl syndromeBardet-Biedl syndrome 1Retinal dystrophy
✦AI Summary

BBS12 is a vertebrate-specific chaperonin-like protein that functions as a component of the TRiC/CCT chaperone complex mediating BBSome assembly 1. As part of this complex, BBS12 interacts with BBSome subunits and CCT chaperonins to facilitate proper protein folding and promote vesicle trafficking to primary cilia during ciliogenesis 1. BBS12 also participates in adipogenic differentiation regulation. Biallelic mutations in BBS12 cause Bardet-Biedl syndrome (BBS), a rare autosomal recessive ciliopathy accounting for approximately 5% of BBS cases 2. Disease-causing mutations, including truncations and frameshifts, impair BBS12 protein stability and disrupt critical protein-protein interactions with other chaperonin-like BBS proteins (BBS6, BBS10) and BBSome core subunits 3. These functional defects compromise BBSome assembly and ciliary length, leading to characteristic BBS features: progressive rod-cone retinal dystrophy, truncal obesity, polydactyly, cognitive impairment, and kidney dysfunction 4. Renal abnormalities represent the most life-threatening complication, potentially progressing to end-stage renal failure 5. BBS12, along with BBS6 and BBS10, defines a vertebrate-specific chaperonin branch accounting for approximately one-third of total BBS mutational burden 2.

Sources cited
1
BBS12 forms a complex with CCT/TRiC chaperonins and mediates BBSome assembly for ciliary vesicle trafficking
PMID: 20080638
2
BBS12 truncating mutations impair protein stability and protein-protein interactions with BBS6, BBS10, and BBSome subunit BBS7
PMID: 40914337
3
BBS12 is a vertebrate-specific chaperonin-related protein accounting for ~5% of BBS cases and defining a novel chaperonin branch with BBS6/BBS10
PMID: 17160889
4
BBS12 mutations cause rod-cone dystrophy, obesity, polydactyly, cognitive impairment, genitourinary malformations, and kidney dysfunction
PMID: 36574078
5
BBS is a ciliopathy with renal abnormalities as the main life-threatening feature potentially leading to end-stage renal failure
PMID: 19019343
Disease Associationsβ“˜21
Bardet-Biedl syndrome 12Open Targets
0.83Strong
Bardet-Biedl syndromeOpen Targets
0.71Strong
Bardet-Biedl syndrome 1Open Targets
0.58Moderate
Retinal dystrophyOpen Targets
0.54Moderate
polydactylyOpen Targets
0.46Moderate
BBS12-related ciliopathyOpen Targets
0.41Moderate
obesityOpen Targets
0.37Weak
eye diseaseOpen Targets
0.37Weak
Abnormal cardiovascular system morphologyOpen Targets
0.34Weak
Inability to walkOpen Targets
0.34Weak
polydactyly, postaxial, type A1Open Targets
0.34Weak
Visual impairmentOpen Targets
0.34Weak
retinitis pigmentosaOpen Targets
0.34Weak
asthmaOpen Targets
0.32Weak
psoriasisOpen Targets
0.31Weak
Abnormality of the nervous systemOpen Targets
0.27Weak
gastritisOpen Targets
0.23Weak
glomerulonephritisOpen Targets
0.23Weak
genetic disorderOpen Targets
0.19Weak
psoriasis vulgarisOpen Targets
0.12Weak
Bardet-Biedl syndrome 12UniProt
Pathogenic Variants183
NM_152618.3(BBS12):c.202C>T (p.Gln68Ter)Pathogenic
Bardet-Biedl syndrome|Bardet-Biedl syndrome 12
β˜…β˜…β˜†β˜†2026β†’ Residue 68
NM_152618.3(BBS12):c.1115_1116del (p.Gly371_Phe372insTer)Pathogenic
Bardet-Biedl syndrome 12|not provided|Bardet-Biedl syndrome|Retinal dystrophy|BBS12-related disorder
β˜…β˜…β˜†β˜†2026β†’ Residue 371
NM_152618.3(BBS12):c.1531_1539del (p.Gln511_Gln513del)Pathogenic
Bardet-Biedl syndrome 12|Retinitis pigmentosa|Bardet-Biedl syndrome|Retinal dystrophy|BBS12-related disorder|not provided
β˜…β˜…β˜†β˜†2026β†’ Residue 511
NM_152618.3(BBS12):c.1949C>G (p.Ser650Ter)Pathogenic
Bardet-Biedl syndrome 12|Bardet-Biedl syndrome
β˜…β˜…β˜†β˜†2026β†’ Residue 650
NM_152618.3(BBS12):c.2060_2063del (p.Asp687fs)Pathogenic
Bardet-Biedl syndrome|Bardet-Biedl syndrome 12|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 687
NM_152618.3(BBS12):c.1719del (p.Ser574fs)Pathogenic
Bardet-Biedl syndrome|Bardet-Biedl syndrome 12
β˜…β˜…β˜†β˜†2025β†’ Residue 574
NM_152618.3(BBS12):c.2023C>T (p.Arg675Ter)Pathogenic
Bardet-Biedl syndrome|Bardet-Biedl syndrome 12|not provided|BBS12-related disorder
β˜…β˜…β˜†β˜†2025β†’ Residue 675
NM_152618.3(BBS12):c.270del (p.Val92fs)Pathogenic
Bardet-Biedl syndrome 12|Bardet-Biedl syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 92
NM_152618.3(BBS12):c.1140_1141del (p.Val381fs)Pathogenic
Bardet-Biedl syndrome 12|Bardet-Biedl syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 381
NM_152618.3(BBS12):c.424dup (p.Asp142fs)Pathogenic
Bardet-Biedl syndrome 12|Bardet-Biedl syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 142
NM_152618.3(BBS12):c.1733C>A (p.Ser578Ter)Pathogenic
Bardet-Biedl syndrome|Bardet-Biedl syndrome 12
β˜…β˜…β˜†β˜†2025β†’ Residue 578
NM_152618.3(BBS12):c.1949del (p.Asn649_Ser650insTer)Pathogenic
Bardet-Biedl syndrome 12|Bardet-Biedl syndrome|BBS12-related disorder
β˜…β˜…β˜†β˜†2025β†’ Residue 649
NM_152618.3(BBS12):c.49dup (p.Gln17fs)Pathogenic
Bardet-Biedl syndrome 12|Bardet-Biedl syndrome|BBS12-related disorder
β˜…β˜…β˜†β˜†2025β†’ Residue 17
NM_152618.3(BBS12):c.1063C>T (p.Arg355Ter)Pathogenic
Bardet-Biedl syndrome 12|Bardet-Biedl syndrome|Abnormal cardiovascular system morphology;Visual impairment;Polydactyly, postaxial, type A1;Inability to walk|Bardet-Biedl syndrome 1|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 355
NM_152618.3(BBS12):c.1151del (p.Ser384fs)Pathogenic
Bardet-Biedl syndrome 12|not provided|Bardet-Biedl syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 384
NM_152618.3(BBS12):c.445C>T (p.Gln149Ter)Pathogenic
Bardet-Biedl syndrome|Bardet-Biedl syndrome 12
β˜…β˜…β˜†β˜†2025β†’ Residue 149
NM_152618.3(BBS12):c.682C>T (p.Gln228Ter)Pathogenic
Bardet-Biedl syndrome 12|Bardet-Biedl syndrome|BBS12-related disorder
β˜…β˜…β˜†β˜†2025β†’ Residue 228
NM_152618.3(BBS12):c.1920_1921del (p.Tyr640_Ser641delinsTer)Pathogenic
Bardet-Biedl syndrome|Bardet-Biedl syndrome 12
β˜…β˜…β˜†β˜†2025β†’ Residue 640
NM_152618.3(BBS12):c.1502C>T (p.Thr501Met)Pathogenic
Bardet-Biedl syndrome|Retinal dystrophy|Bardet-Biedl syndrome 12|not provided|BBS12-related disorder
β˜…β˜…β˜†β˜†2025β†’ Residue 501
NM_152618.3(BBS12):c.1993GTT[1] (p.Val666del)Pathogenic
Bardet-Biedl syndrome|Bardet-Biedl syndrome 12
β˜…β˜…β˜†β˜†2025β†’ Residue 666
View on ClinVar β†—
Related Genes
BBS2Protein interaction97%BBS4Protein interaction97%TRIM32Protein interaction97%BBS9Protein interaction97%WDPCPProtein interaction97%LZTFL1Protein interaction97%
Tissue Expression6 tissues
Heart
100%
Ovary
40%
Brain
38%
Lung
29%
Liver
13%
Bone Marrow
9%
Gene Interaction Network
Click a node to explore
BBS12BBS2BBS4TRIM32BBS9WDPCPLZTFL1
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt Q6ZW61
View on AlphaFold β†—
Constraintβ“˜
LOEUFβ“˜
1.42LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.79 [0.46–1.42]
RankingsWhere BBS12 stands among ~20K protein-coding genes
  • #13,837of 20,598
    Most Researched21
  • #388of 5,498
    Most Pathogenic Variants183 Β· top 10%
  • #14,639of 17,882
    Most Constrained (LOEUF)1.42
Genes detectedBBS12
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
PMID: 20301537
1.00
2
Truncating mutations in BBS10 and BBS12 impair proteostasis and ciliary architecture in Bardet-Biedl Syndrome.
PMID: 40914337
Exp Eye Res Β· 2025
0.90
3
[Bardet-Biedl syndrome].
PMID: 19019343
Ann Endocrinol (Paris) Β· 2008
0.80
4
BBS6, BBS10, and BBS12 form a complex with CCT/TRiC family chaperonins and mediate BBSome assembly.
PMID: 20080638
Proc Natl Acad Sci U S A Β· 2010
0.70
5
Diagnosis and genetic analysis of a case with Bardet-Biedl syndrome caused by compound heterozygous mutations in the BBS12 gene.
PMID: 36384733
Yi Chuan Β· 2022
0.60